Clinical Trials Logo

Clinical Trial Summary

The objective of this study is to evaluate the safety and efficacy of 1064-nm Picosecond laser 1064 With Microlens Array for Pore tightening.


Clinical Trial Description

The Safety and Efficacy of Picosecond laser 1064 Nanometers With Microlens Array for Pore tightening; a Pilot Study Primary outcome : pore size Secondary outcome : side effect, patient satisfaction, global evaluation the patient recieved laser treament once a month for 3 months and then follow up after last treatment at 1, 3 ,6 month Enlarged facial pores is one of the skin signs in photoaging. There are 3 major clinical causes of enlarged facial pores: highs sebum excretion, decreased elasticity around pores and increased hair follicle volume. Possible causative factors of enlarged facial pores include many exogenous and endogenous factors include genetic predisposition, seborrhea and chronic ultraviolet light exposure. Picosecond laser are new device which has been used in skin rejuvenation. The main mechanism of action is laser induced optical breakdown (LIOB). ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04471948
Study type Interventional
Source Mahidol University
Contact woraphong Manuskiatti, M.D.
Phone 02-419-1000
Email doctorlaser@gmail.com
Status Recruiting
Phase N/A
Start date May 7, 2020
Completion date March 7, 2021

See also
  Status Clinical Trial Phase
Completed NCT05097157 - Study To Assess A Radiofrequency Microneedling Device For Dermatologic Conditions N/A
Completed NCT05254210 - Feasibility Study To Collect Safety And Preliminary Efficacy Data For A Radiofrequency Microneedling Device N/A
Recruiting NCT05784363 - A Study of NT 201 in the Treatment of Enlarged Pores and Excessive Sebum Production in the Face Phase 1
Active, not recruiting NCT02544958 - Er:YAG Laser for Treatment of Enlarged Pores N/A
Recruiting NCT05987319 - Feasibility Study to Collect and Assess Safety Data for a Radiofrequency Microneedling Device for Electrocoagulation and Hemostasis of Soft Tissues for Dermatologic Conditions N/A
Active, not recruiting NCT06293755 - Microneedle Patch With Botulinum Toxin in Management of Enlarged Facial Pores Phase 3